rx 821002 has been researched along with dsp 4 in 2 studies
| Studies (rx 821002) | Trials (rx 821002) | Recent Studies (post-2010) (rx 821002) | Studies (dsp 4) | Trials (dsp 4) | Recent Studies (post-2010) (dsp 4) |
|---|---|---|---|---|---|
| 317 | 0 | 45 | 572 | 0 | 80 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buckett, WR; Butler, SA; Cheetham, SC; Gosden, J; Heal, DJ; Prow, MR | 1 |
| Bylund, DB; Happe, HK; Murrin, LC; Sanders, JD | 1 |
2 other study(ies) available for rx 821002 and dsp 4
| Article | Year |
|---|---|
Receptor binding and functional evidence suggest that postsynaptic alpha 2-adrenoceptors in rat brain are of the alpha 2D subtype.
Topics: Adrenergic Agents; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Benzylamines; Binding Sites; Binding, Competitive; Cerebral Cortex; Clonidine; Dioxanes; Dopamine; Idazoxan; Male; Mydriasis; Neurons; Norepinephrine; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Serotonin; Zimeldine | 1995 |
Differential effects of neonatal norepinephrine lesions on immediate early gene expression in developing and adult rat brain.
Topics: Adrenergic Agents; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Animals, Newborn; Autoradiography; Benzylamines; Brain; Cytoskeletal Proteins; Early Growth Response Protein 1; Female; Gene Expression Regulation, Developmental; Idazoxan; Immediate-Early Proteins; Male; Nerve Tissue Proteins; Norepinephrine; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley | 2008 |